Works matching Multiple sclerosis treatment

Results: 5000

Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects.

Published in:

BioDrugs, 1999, v. 12, n. 4, p. 267, doi. 10.2165/00063030-199912040-00004

By:

Rice, G.P.A.

Publication type:

Article

Early-Stage Multiple Sclerosis: What Are the Treatment Options?

Published in:

Drugs, 2004, v. 64, n. 18, p. 2021, doi. 10.2165/00003495-200464180-00002

By:

Sorensen, Per Soelberg

Publication type:

Article

Treatment of Multiple Sclerosis with the Interferon-βs: Comparative Risks and Benefits.

Published in:

BioDrugs, 1998, v. 10, n. 6, p. 463, doi. 10.2165/00063030-199810060-00004

By:

Herndon, R.M.

Publication type:

Article

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

Published in:

CNS Drugs, 1999, v. 11, n. 2, p. 133, doi. 10.2165/00023210-199911020-00005

By:

Weilbach, F.X.;
Gold, R.

Publication type:

Article

Agresyvios eigos recidyvuojančios remituojančios išsėtinės sklerozės gydymas natalizumabu.

Published in:

Neurologijos Seminarai, 2012, v. 16, n. 4, p. 289

By:

Aleknaitė, L.;
Kizlaitienė, R.;
Kaubrys, G.;
Budrys, V.

Publication type:

Article

Localized Panniculitis and Subsequent Lipoatrophy with Subcutaneous Glatiramer Acetate (Copaxone<sup>®</sup>) Injection for the Treatment of Multiple Sclerosis.

Published in:

American Journal of Clinical Dermatology, 2004, v. 5, n. 5, p. 357, doi. 10.2165/00128071-200405050-00009

By:

Soós, Noemi;
Shakery, Kaweh;
Mrowietz, Ulrich

Publication type:

Article

What is New in the Treatment of Multiple Sclerosis?

Published in:

Drugs, 2000, v. 59, n. 3, p. 401, doi. 10.2165/00003495-200059030-00002

By:

Weinstock-Guttman, B.;
Jacobs, L.D.

Publication type:

Article

Combination therapy for multiple sclerosis: the treatment strategy of the future?

Published in:

2004

By:

Weinstock-Guttman, Bianca;
Bakshi, Rohit

Publication type:

journal article

Long-term treatment of multiple sclerosis with interferon-beta may be cost effective.

Published in:

2000

By:

Kendrick, M.;
Johnson, K.I.

Publication type:

journal article

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Published in:

2018

By:

Riordan, Neil H.;
Morales, Isabela;
Fernández, Giselle;
Allen, Nicole;
Fearnot, Neal E.;
Leckrone, Michael E.;
Markovich, Dedra Jones;
Mansfield, Darla;
Avila, Dorita;
Patel, Amit N.;
Kesari, Santosh;
Paz Rodriguez, Jorge;
Fernández, Giselle

Publication type:

journal article

2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis-European Committee for Treatment and Research in Multiple Sclerosis Meeting.

Published in:

Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 1, p. 100, doi. 10.1111/cen3.12171

By:

Sato, Douglas Kazutoshi

Publication type:

Article

Congress report of the sixth triennial joint Americas Committee for Treatment and Research in Multiple Sclerosis-European Committee for Treatment and Research in Multiple Sclerosis meeting in Boston.

Published in:

Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 1, p. 103, doi. 10.1111/cen3.12176

By:

Takata, Kazushiro

Publication type:

Article

Current issues in immunomodulatory treatment of multiple sclerosis: A practical approach.

Published in:

Journal of Neurology, 2006, v. 253, p. I32, doi. 10.1007/s00415-006-1108-9

By:

Stangel, Martin;
Gold, Ralf;
Gass, Achim;
Haas, Judith;
Jung, Stefan;
Elias, Wolfgang;
Uwe K. Zettl

Publication type:

Article

A regenerative approach to the treatment of multiple sclerosis.

Published in:

Nature, 2013, v. 502, n. 7471, p. 327, doi. 10.1038/nature12647

By:

Deshmukh, Vishal A.;
Tardif, Virginie;
Lyssiotis, Costas A.;
Green, Chelsea C.;
Kerman, Bilal;
Kim, Hyung Joon;
Padmanabhan, Krishnan;
Swoboda, Jonathan G.;
Ahmad, Insha;
Kondo, Toru;
Gage, Fred H.;
Theofilopoulos, Argyrios N.;
Lawson, Brian R.;
Schultz, Peter G.;
Lairson, Luke L.

Publication type:

Article

Multiple sclerosis: Closing in on an oral treatment.

Published in:

Nature, 2010, v. 464, n. 7287, p. 360, doi. 10.1038/464360a

By:

Martin, Roland

Publication type:

Article

The IMCO Scheme as a Tool in Developing Team-Based Treatment for People with Multiple Sclerosis.

Published in:

Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 1, p. 69, doi. 10.1089/acm.2007.0593

By:

Launsø, Laila;
Skovgaard, Lasse

Publication type:

Article

Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report.

Published in:

Journal of Central Nervous System Disease, 2020, p. 1, doi. 10.1177/1179573520973820

By:

Iovino, Aniello;
Aruta, Francesco;
Dubbioso, Raffaele;
Ruggiero, Lucia;
Tozza, Stefano;
Spina, Emanuele;
Manganelli, Fiore;
Iodice, Rosa

Publication type:

Article

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.

Published in:

Journal of Neurology, 2018, v. 265, n. 3, p. 701, doi. 10.1007/s00415-018-8764-4

By:

Landfeldt, Erik;
Castelo-Branco, Anna;
Svedbom, Axel;
Löfroth, Emil;
Kavaliunas, Andrius;
Hillert, Jan

Publication type:

Article

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.

Published in:

Journal of Neurology, 2012, v. 259, n. 9, p. 1814, doi. 10.1007/s00415-012-6414-9

By:

Fernández, O.;
Oreja-Guevara, C.;
Arroyo, R.;
Izquierdo, G.;
Pérez, J.;
Montalban, X.

Publication type:

Article

European and American Guidelines for Multiple Sclerosis Treatment.

Published in:

Neurology & Therapy, 2018, v. 7, n. 2, p. 189, doi. 10.1007/s40120-018-0112-1

By:

Ghezzi, Angelo

Publication type:

Article

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 1123, doi. 10.2147/PPA.S68698

By:

Caporro, Matteo;
Disanto, Giulio;
Gobbi, Claudio;
Zecca, Chiara

Publication type:

Article

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 4, p. 503, doi. 10.1177/1352458509359727

By:

Freedman, Mark S.;
Bar-Or, Amit;
Atkins, Harold L.;
Karussis, Dimitrios;
Frassoni, Francesco;
Lazarus, Hillard;
Scolding, Neil;
Slavin, Shimon;
Le Blanc, Katarina;
Uccelli, Antonio

Publication type:

Article

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 10, p. 1175, doi. 10.1177/1352458509107007

By:

Goodin, D. S.;
Bates, D.

Publication type:

Article

Systematic review of the association between interferon treatment and depression in patients with multiple sclerosis.

Published in:

European Psychiatry, 2016, v. 33, p. S179, doi. 10.1016/j.eurpsy.2016.01.307

By:

Alba Palé, L.;
Samsó Buxareu, B.;
León Caballero, J.;
Chavarria Romero, V.;
Pérez Sánchez, E.J.;
Palma Conesa, A.J.;
Ginés Miranda, J.M.;
Salgado Serrano, P.;
Perez Sola, V.

Publication type:

Article

Clinical Roundup: Selected Treatment Options for Multiple Sclerosis—Part 2.

Published in:: Alternative & Complementary Therapies, 2019, v. 25, n. 5, p. 269, doi. 10.1089/act.2019.29236.cru
Publication type:: Article

A REVIEW ON ADVANCEMENTS IN MULTIPLE SCLEROSIS AND ITS TREATMENT.

Published in:

Journal of Advanced Scientific Research, 2020, v. 11, n. 2, p. 10

By:

Bhuvaneswari, Mylipilli;
Prabhakar, Orsu;
Arun, Koyyada

Publication type:

Article

Multiple sclerosis: effect of beta interferon treatment on survival.

Published in:

2019

By:

Kingwell, Elaine;
Leray, Emmanuelle;
Zhu, Feng;
Petkau, John;
Edan, Gilles;
Oger, Joel;
Tremlett, Helen

Publication type:

journal article

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.

Published in:

2017

By:

Guarnera, Cristina;
Bramanti, Placido;
Mazzon, Emanuela

Publication type:

journal article

HISTORY OF INTERFERON TREATMENTS IN MULTIPLE SCLEROSIS - 60 YEARS OF PROGRESS.

Published in:

Farmacia, 2017, v. 65, n. 1, p. 14

By:

SÎRBU, CARMEN ADELLA;
DRĂGOI, CRISTINA MANUELA;
NICOLAE, ALINA CRENGUȚA;
PLEȘA, CRISTINA FLORENTINA

Publication type:

Article

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.

Published in:

Immunity, Inflammation & Disease, 2015, v. 3, n. 2, p. 45, doi. 10.1002/iid3.42

By:

Stasiolek, Mariusz;
Linker, Ralf A.;
Hayardeny, Liat;
Bar Ilan, Oren;
Gold, Ralf

Publication type:

Article

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.

Published in:

Frontiers in Neurology, 2018, p. 1, doi. 10.3389/fneur.2018.00005

By:

Mills, Elizabeth A.;
Ogrodnik, Magdalena A.;
Plave, Andrew;
Mao-Draayer, Yang

Publication type:

Article

Türkiye'de Mııltipl Skleroz Hastalığının Tanı ve Tedavisine Genel Yaklaşım.

Published in:

Turkish Journal of Neurology / Turk Noroloji Dergisi, 2009, v. 15, n. 3, p. 124

By:

Terzi, Murat;
Çelik, Yahya;
Kilinç, Münire;
Seleker, Feray;
Iflik, Nihal;
Gedizlioğlu, Muhteflem;
Zorlu, Yaflar

Publication type:

Article

THE ROLE OF THE RECOVERY PROGRAM IN THE TREATMENT OF MULTIPLE SCLEROSIS.

Published in:

2017

By:

I. S., Neagoie;
D., Cinteză

Publication type:

Abstract

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

Published in:

Acta Neurologica Scandinavica, 2017, v. 135, n. 4, p. 394, doi. 10.1111/ane.12612

By:

Skierlo, S.;
Rommer, P. S.;
Zettl, U. K.

Publication type:

Article

Gender effects on treatment response to interferon-beta in multiple sclerosis.

Published in:

Acta Neurologica Scandinavica, 2014, v. 130, n. 6, p. 374, doi. 10.1111/ane.12277

By:

Magyari, M.;
Koch‐Henriksen, N.;
Laursen, B.;
Sørensen, P. S.

Publication type:

Article

Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.

Published in:

2018

By:

Cramer, Stig P.;
Simonsen, Helle J.;
Varatharaj, Aravinthan;
Galea, Ian;
Frederiksen, Jette L.;
Larsson, Henrik B. W.

Publication type:

journal article

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.

Published in:

BMC Complementary & Alternative Medicine, 2012, v. 12, n. 1, p. 209, doi. 10.1186/1472-6882-12-209

By:

Quispe-Cabanillas, Juan G.;
Damasceno, Alfredo;
von Glehn, Felipe;
Brandão, Carlos O.;
Damasceno, Benito P.;
Silveira, Wanderley D.;
Santos, Leonilda M. B.

Publication type:

Article

Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 4, p. 353, doi. 10.1007/s10198-013-0478-z

By:

Dembek, Carole;
White, Leigh;
Quach, Jayson;
Szkurhan, Andrea;
Rashid, Nazia;
Blasco, M.

Publication type:

Article

Multiple sclerosis and pregnancy - treatment considerations.

Published in:

Journal of Pre-Clinical & Clinical Research, 2020, v. 14, n. 4, p. 126, doi. 10.26444/jpccr/127671

By:

Kamieniak, Maciej Piotr;
Wolanin, Natalia;
Jarosz, Piotr;
Kobiałka, Izabela;
Kośmider, Kamil;
Petit, Véronique;
Rejdak, Konrad

Publication type:

Article

Considerations for the treatment of multiple sclerosis in the managed care setting.

Published in:

Formulary, 2003, v. 38, n. 11, p. 646

By:

Morrow, Thomas;
Brown, Jean;
Smith, Craig;
Thrower, Ben

Publication type:

Article

Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2017: Environmental factors, genetics, and epigenetics in MS susceptibility and clinical course.

Published in:

Multiple Sclerosis Journal, 2018, v. 24, n. 1, p. 4, doi. 10.1177/1352458517737397

By:

Segal, Benjamin M.;
Cohen, Jeffrey A.;
Antel, Jack

Publication type:

Article

Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 14, p. 1888, doi. 10.1177/1352458516645868

By:

Papathemeli, Despoina;
Gräfe, Ronald;
Ulrich, Jens;
Hildebrandt, Uwe;
Zettl, Uwe K.

Publication type:

Article

Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 926, doi. 10.1177/1352458515605908

By:

Ratzer, Rikke;
Iversen, Pernille;
Börnsen, Lars;
Dyrby, Tim B.;
Romme Christensen, Jeppe;
Ammitzbøll, Cecilie;
Madsen, Camilla Gøbel;
Garde, Ellen;
Lyksborg, Mark;
Andersen, Birgit;
Hyldstrup, Lars;
Sørensen, Per Soelberg;
Siebner, Hartwig R.;
Sellebjerg, Finn

Publication type:

Article

Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1355, doi. 10.1177/1352458514521887

By:

Amor, Sandra;
van der Star, Baukje J;
Bosca, Isabel;
Raffel, Joel;
Gnanapavan, Sharmilee;
Watchorn, Jonathan;
Kuhle, Jens;
Giovannoni, Gavin;
Baker, David;
Malaspina, Andrea;
Puentes, Fabiola

Publication type:

Article

Disease-modifying treatments for progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 11, p. 1428, doi. 10.1177/1352458513502572

By:

Comi, Giancarlo

Publication type:

Article

Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 11, p. 1550, doi. 10.1177/1352458513490549

By:

Ferraro, D;
Federzoni, L;
Vitetta, F;
Simone, AM;
Cossarizza, A;
Nichelli, PF;
Sola, P

Publication type:

Article

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 622, doi. 10.1177/1352458512461391

By:

Wickström, Anne;
Nyström, Josefina;
Svenningsson, Anders

Publication type:

Article

Intramuscular interferon beta-1a is effective in Japanese patients with relapsing–remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1782, doi. 10.1177/1352458512442261

By:

Saida, Takahiko;
Itoyama, Yasuto;
Tashiro, Kunio;
Kira, Jun-ichi;
Hao, Qi

Publication type:

Article

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review.

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1705, doi. 10.1177/1352458512438239

By:

Balak, Deepak MW;
Hengstman, Gerald JD;
Çakmak, Aysun;
Thio, H Bing

Publication type:

Article

Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 11, p. 1617, doi. 10.1177/1352458512449681

By:

Conway, Devon S;
Miller, Deborah M;
O’Brien, Ralph G;
Cohen, Jeffrey A

Publication type:

Article